Contrarily to most obesity-related pathologies, such as type 2 Diabetes mellitus or atherosclerosis, increased serum levels of adiponectin have been associated with an increased risk of knee OA, although with controversial associations. Here, ADIPOQ is linked to type 2 diabetes mellitus.